Electronic cigarette use among patients with cancer: Characteristics of electronic cigarette users and their smoking cessation outcomes

Cancer

Volumn 120, Issue 22, 2014, Pages 3527-3535

  Borderud, Sarah P ^a   Li, Yuelin ^a   Burkhalter, Jack E ^a   Sheffer, Christine E ^b   Ostroff, Jamie S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

cancer; electronic cigarettes (E cigarettes); smoking cessation; tobacco

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; ELECTRONIC CIGARETTE; FEMALE; FEMALE GENITAL TRACT CANCER; FOLLOW UP; HEAD AND NECK CANCER; HEALTH HAZARD; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INSTITUTIONAL REVIEW; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; ONCOLOGIST; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TOBACCO USE; UROGENITAL TRACT CANCER;

EID: 85007189030     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28811     Document Type: Article

References (39)

1. US Department of Health and Human Services. The Health Consequences of Smoking–50 years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
2. Gajdos C, Hawn MT, Campagna EJ, Henderson WG, Singh JA, Houston T. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol. 2012;19:1430-1438.
3. Daniel M, Keefe FJ, Lyna P, et al. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain. 2009;10:323-328.
4. Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132:401-410.
5. Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS; AACR Subcommittee on Tobacco and Cancer. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. 2013;19:1941-1948.
6. Morgan G, Schnoll RA, Alfano CM, et al. National cancer institute conference on treating tobacco dependence at cancer centers. J Oncol Pract. 2011;7:178-182.
7. Sarna L, Brown JK, Lillington L, Wewers ME, Brecht ML. Tobacco-control attitudes, advocacy, and smoking behaviors of oncology nurses. Oncol Nurs Forum. 2000;27:1519-1528.
8. Hanna N. Helping patients quit tobacco: ASCO's efforts to help oncology care specialists. J Oncol Pract. 2013;9:263-264.
9. Tseng TS, Lin HY, Moody-Thomas S, Martin M, Chen T. Who tended to continue smoking after cancer diagnosis: the national health and nutrition examination survey 1999-2008. BMC Public Health. 2012;12:784.
10. Fiore M. United States Tobacco Use and Dependence Guideline Panel: Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.
11. Goldstein AO, Ripley-Moffitt CE, Pathman DE, Patsakham KM. Tobacco use treatment at the U.S. National Cancer Institute's designated Cancer Centers. Nicotine Tob Res. 2013;15:52-58.
12. Warren GW, Marshall JR, Cummings KM, et al. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. 2013;9:258-262.
13. Sabatino SA, Coates RJ, Uhler RJ, Pollack LA, Alley LG, Zauderer LJ. Provider counseling about health behaviors among cancer survivors in the United States. J Clin Oncol. 2007;25:2100-2106.
14. Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA. 2014;311:135-136.
15. Cobb NK, Abrams DB. E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med. 2011;365:193-195.
16. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the “e-cigarette.” Am J Public Health. 2010;100:2340-2342.
17. Huang J, Chaloupka FJ, Emery S. Rapid Rise of Electronic Cigarettes: Public Health and Policy Implications. Presented at 141st American Public Health Association Annual Meeting; November 2-November 6, 2013; Boston, MA.
18. McMillen RC, Gottlieb MA, Winickoff JP, Klein J, editors. Three year trends in the use of emerging tobacco products. Presented at 141st American Public Health Association Annual Meeting; November 2-November 6, 2013; Boston, MA.
19. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011;106:2017-2028.
20. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. e-Cigarette awareness, use, and harm perceptions in US adults. Am J Public Health. 2012;102:1758-1766.
21. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health. 2013;103:923-930.
22. Adkison SE, O'Connor RJ, Bansal-Travers M, et al. Electronic nicotine delivery systems: international tobacco control 4-country survey. Am J Prev Med. 2013;44:207-215.
23. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res. 2013;15:1787-1791.
24. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382:1629-1637.
25. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8:e66317.
26. Cummings KM, Dresler CM, Field JK, et al. E-cigarettes and cancer patients. J Thorac Oncol. 2014;9:438-441.
27. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addiction. 1991;86:1119-1127.
28. Hall SM, Delucchi KL, Velicer WF, et al. Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome. Nicotine Tob Res. 2001;3:193-202.
29. Nelson DB, Partin MR, Fu SS, Joseph AM, An LC. Why assigning ongoing tobacco use is not necessarily a conservative approach to handling missing tobacco cessation outcomes. Nicotine Tob Res. 2009;11:77-83.
30. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003;5:13-25.
31. Sheffer CE, Stitzer M, Payne TJ, Applegate BW, Bourne D, Wheeler JG. Treatment for tobacco dependence for rural, lower-income smokers: outcomes, predictors, and measurement considerations. Am J Health Promot. 2009;23:328-338.
32. Dockrell M, Morrison R, Bauld L, McNeill A. E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob Res. 2013;15:1737-1744.
33. King B, Alam S, Promoff G, Arrazola R, Dube S. Awareness and ever use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res. 2013;15:1623-1627.
34. Kasza KA, Bansal-Travers M, O'Connor RJ, et al. Cigarette smokers' use of unconventional tobacco products and associations with quitting activity: findings from the ITC-4 U.S. Cohort. Nicotine Tob Res. 2014;16:672-681.
35. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med. 2014;174:812-813.
36. Park ER, Japuntich SJ, Rigotti NA, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer. 2012;118:3153-3164.
37. Simmons VN, Litvin EB, Jacobsen PB, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013;119:1420-1427.
38. Maher JE, Rohde K, Dent CW, et al. Is a statewide tobacco quiteline an appropriate service for specific populations? Tob Control. 2007;16(suppl 1):i65-i70.
39. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133-139.